Biosensors for determination of multiple neurotransmitters in vertebrate retina

用于测定脊椎动物视网膜中多种神经递质的生物传感器

基本信息

批准号：
10459565
负责人：
XIANGQUN ZENG
金额：
$ 17.84万
依托单位：
OAKLAND UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2021
资助国家：
美国
起止时间：
2021-09-01 至 2024-08-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10459565
关键词：
Acetylcholine Acids Acoustics Adsorption Adult Amacrine Cells Amino Acids Biological Models Biosensor Blindness Brain Cells Charge Chemistry Cone Detection Development Devices Diabetic Retinopathy Disease Dopamine Electrochemistry Electrodes Electrophysiology (science)Eye Development Eye diseases Film Fluorescence Functional disorder Future Goals In Vitro Interneurons Label Light Measures Mediating Methods Microelectrodes Miniaturization Monitor Motion Myopia Nanostructures Neuraxis Neurodegenerative Disorders Neuromodulator Neurons Neurotransmitters Ocular Physiology Optic Nerve Output Oxidation-Reduction Pathway interactions Peptides Photophobia Photoreceptors Play Property Proteins Reagent Research Retina Retinal Diseases Rod Role Shapes Signal Transduction Structure Surface Techniques Technology Therapeutic Agents Thinness Time Tissues Transgenic Mice Validation Vertebrate Photoreceptors Vision Visual Visual system structure Visualization Work analytical method base carbon fiber cross reactivity design detection limit detection method diabetic gamma-Aminobutyric Acid ganglion cell horizontal cell in vivo information processing microdevice microsensor miniaturize multidisciplinary multimodality nanoparticle neurophysiology neurotransmitter release new technology novel prototype real time monitoring retinal neuron sensor starburst amacrine cell systems research temporal measurement therapeutic evaluation tool transmission process visual information visual neuroscience

项目摘要

Project Summary: The long-term goal of this project is to develop a paradigm-shifting neurosensing technology for direct, simultaneous monitoring of the activity of multiple neurotransmitters for understanding brain function. The retina is selected as our model system due to its easy accessibility and well-established neurophysiology and the urgent needs in such tool to understand the roles of neurotransmitters in various eye diseases such as diabetic retinopathy. Retinal photosensitive cells (rods and cones) convert light into an electrical signal. The electrical signal is transmitted through bipolar cells to ganglion cells, the output neurons of the retina, and then to the brain. Signal transmission through this pathway is modulated by amacrine cells, which are retinal interneurons. There are multiple types of amacrine cells, but all synthesize and release neuromodulators such as dopamine (DA), gamma-aminobutyric acid (GABA) and acetylcholine (ACh). Specifically, dopaminergic amacrine cells (DACs) co-release GABA and DA, which play a critical role in modulating retinal light sensitivity and eye development. Starburst amacrine cells co-release GABA and ACh, which initiates the motion direction of the visual system. Historically, the release of neurotransmitters from retinal neurons and amacrine cells has been studied indirectly, through electrophysiological methods and/or redox detection using electroanalytical techniques employing carbon fiber microelectrodes. However, electrical activity in a cell does not always match the release of neurotransmitter from the cell. Redox methods only work for a relatively small number of analytes such as DA. We have constructed a novel biosensor that employs complementary electrochemical and piezoelectric sensors, and our preliminary results show that it can differentiate between redox and non-redox active neurotransmitters. The objective of this R21 project is to develop a miniaturized multimodal biosensor to measure multiple neurotransmitters simultaneously with high spatial and temporal resolution in real time, label- and reagent-free with two Aims: 1. Design, fabrication, and characterization of a miniaturized multimodal electrochemical (E) and piezoelectric sensor (thin film bulk acoustic resonator (FBAR) (i.e. E-FBAR) neurosensing probe; and 2: Validation of the neurosensing probe through monitoring dopamine, GABA, and ACh in living normal and diabetic retinal neurons. Successful completion of this project will certify a reagent-free, label-free and real-time simultaneously detection of both redox active and non-redox active neurotransmitters in retina with multifaceted information in high sensitivity and selectivity. Such a tool will be invaluable to research aimed at understanding the causes and mechanisms responsible for retinal neurodegenerative diseases such as diabetic retinopathy, and also to test therapeutic agents for the treatment of such diseases. This novel technology could also be adapted to monitor other important neurotransmitters in the brain, increasing our understanding of brain functions. Our well- established, highly skilled, multidisciplinary team has the expertise in electrochemical and acoustic biosensors, microdevice and microsensor design and fabrication, and visual neuroscience to develop and validate the proposed neurosensing technology.

项目摘要：该项目的长期目标是开发范式转移神经传感技术直接，同时监测多个神经递质的活性，以理解大脑功能。视网膜被选为我们的模型系统，因为它易于访问和建立的神经生理学以及这种工具的紧急需求，以了解神经递质在各种眼部疾病中的作用，例如糖尿病性视网膜病。视网膜光敏细胞（杆和锥体）将光转换为电信号。这电信号通过双极细胞传播到神经节细胞，视网膜的输出神经元，然后到大脑。通过该途径传播的信号传播是由视网膜的无聚细胞调节的中间神经元。有多种类型的无结合细胞，但所有类型都合成并释放神经调节剂此类如多巴胺（DA），γ-氨基丁酸（GABA）和乙酰胆碱（ACH）。具体而言，多巴胺能无大细胞（DACS）共释GABA和DA，它们在调节视网膜光敏感性中起关键作用和眼睛发育。 Starburst Amacrine细胞共释放GABA和ACH，它启动了运动方向视觉系统。从历史上看，视网膜神经元和无链氨酸细胞的神经递质的释放具有通过电生理方法和/或使用电分析的氧化还原检测间接研究了采用碳纤维微电极的技术。但是，细胞中的电活动并不总是匹配神经递质从细胞释放。氧化还原方法仅适用于相对较少的分析物例如da。我们已经构建了一种新颖的生物传感器，该生物传感器采用了互补的电化学和压电传感器，我们的初步结果表明，它可以区分氧化还原和非雷多斯活性神经递质。该R21项目的目的是开发一个小型化的多模式生物传感器同时测量多个神经递质，并实时使用高空间和时间分辨率并具有两个目标的无试剂：1。设计，制造和表征微型模式电化学（E）和压电传感器（薄膜散装声音谐振器（FBAR）（即E-FBAR）神经传感探针；和2：通过监测多巴胺，GABA和ACH验证神经传感探针在生活正常和糖尿病性视网膜神经元中。成功完成该项目将获得无试剂的证明，同时检测无标签和实时的氧化还原活性和非雷克斯主动神经递质视网膜具有高灵敏度和选择性的多方面信息。这样的工具对于研究将是无价的旨在理解负责视网膜神经退行性疾病的原因和机制作为糖尿病性视网膜病，也可以测试治疗此类疾病的治疗剂。这本小说技术也可以适应以监测大脑中其他重要的神经递质，从而增加了我们的了解大脑功能。我们建立的，高技能，多学科团队具有专业知识在电化学和声学生物传感器中，微电位和微传感器设计和制造以及视觉神经科学开发和验证所提出的神经传感技术。